Gámez PA, Rodríguez OCA, Arteaga BJM, Díaz RDR, Concepción LA, Ricardo SO, López GE, González CF, Pérez CD, González PY, Pérez MDS, Echemendía RAL, Ginebra CF, Saavedra MN

Language: Spanish
References: 18
Page: 164-174
PDF size: 135.22 Kb.

ABSTRACT

Introduction: platelet-derived growth factors are bio-active proteins that are synthesized and stored in the platelets.
Objective: to evaluate the effectiveness of allogenic platelet lysate-derived growth factors in the topical treatment of postphlebitis ulcers.
Methods: a quasi-experimental study with simultaneous control was conducted from January 2008 through December 2012 in the regenerative medicine service of "Comandante Pinares" general teaching hospital located in San Cristobal, Artemisa province, Cuba. One hundred and thirty five patients with diagnosis of postphlebitis ulcers, inadequate response to the conventional treatment and absence of other illnesses that could hinder such response to regenerative therapy were evaluated. The patients were divided into two groups: 90 treated with local use of compatible ABO allogenic platelet-derived platelet lysate and 45 kept under the conventional treatment (control group). The reaction time was the distinctive characteristic to measure the effectiveness of both treatments.
Results: females and over 50 years-old age predominated. The main symptoms of the posphlebitic syndrome were present in a high number of patients in the group treated with the platelet lysate. Thirty days later, these symptoms significantly improved and the average ulcer area dramatically decreased. There was observed symptoms remission in eighty six patients in less than six weeks in contrast with only eight in the conventional group during this period.
Conclusions: the use of allogenic platelet lysate-derived growth factors was effective in the topical treatment of postphlebitis ulcers.

REFERENCES

1. Levy-Montalcini R, Cohen S. Effects of the extract of the mouse submaxillary salivary glands on the sympathetic system of mammals. Ann NY Acad Sci. 1960;85:324-41.

2. Knighton DR, Ciresi K, Fiegel VD, Schumerth S, Mayordomo E, Cerra F. Stimulation of repair in chronic, nonhehaling, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet. 1990;170(1):56-60.

3. Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release. 2012;157(1):29-38.

4. Fernández-Delgado N, Hernández-Ramírez P, Forrellat-Barrios M. Espectro funcional de las plaquetas: de la hemostasia a la medicina regenerativa. Rev Cubana Hematol Inmunol Hemoter. 2012 [citado 19 Jun 2014];28(3):200-16. Disponible en: http://scielo.sld.cu/pdf/hih/v28n3/hih02312.pdf

5. Álvarez P, Hee CK, Solchaga L, Snel L, Kestler HK, Lynch SE, et al. Growth factors and cranio-facial surgery. J Craniofac Surg. 2012;23(1):20-9.

6. Gámez-Pérez A, Arteaga-Báez JM, Rodríguez-Orta CA, Saavedra-Martínez N, González-Cordero F, Sanabria-Negrín JG, et al. Aplicación local de lisado plaquetario en úlceras postflebíticas. Rev Cubana Hematol Inmunol Hemoter. 2012 [citado 19 Jun 2014];28(4):374-84. Disponible en: http://scielo.sld.cu/pdf/hih/v28n4/hih06412.pdf

7. Collazo Álvarez H, Collazo Marin SY, Boada NM. Factores de crecimiento plaquetarios en lesiones traumáticas óseas y pseudotumorales. Rev Cubana Hematol Inmunol Hemoter. Resúmenes Orales Hematología. Resumen 3-3-21. 2009 [citado 19 Jun 2014];25(1 Supl. A1). Disponible en: http://bvs.sld.cu/revistas/hih/vol25-4- 09/hih02409.htm

8. Balbo R, Avonto I, Marenchino D, Maddalena L, Menardi G, Peano G. Platelet gel for the treatment of traumatic loss of finger substance. Blood Transfus. 2010;8(4):255-9.

9. Mateo de Acosta D, Porres M, Vázquez DG, Makipour J, Bedolla E. Actualización bibliográfica sobre el uso de preparaciones ricas en plaquetas en la cicatrización de heridas. Cir Plást Iberolatinoam. 2010 [citado 19 Jun 2014];36(3):231-8. Disponible en: http://www.scielo.isciii.es/scielo.php?pid=S0376- 78922010000300005&script=sci_arttext

10. Bencomo Hernández AA. Los derivados plaquetarios en medicina regenerativa [editorial] Rev Cubana Hematol Inmunol Hemoter 2012 [citado 19 Jun 2014];28(4):308-9. Disponible en: http://scielo.sld.cu/pdf/hih/v28n4/hih01412.pdf

11. Backly R, Ulivi V, Tonachini L, Cancedda R, F Descalzi, Mastrogiacomo M. Platelet lysate induces in vitro wound healing of human keratinocyhtes associated with a strong proinflammatory response. Tissue Eng: Part A. 2011;17(13-14):1787-800.

12. Carrasco J, Bonete D, Gomar F. Plasma rico en plaquetas vs plasma rico en factores de crecimiento. Rev Esp Cir Osteoartic. 2009;46(239):127-40.

13. Gámez-Pérez A, Arteaga-Báez JM, Rodríguez-Orta CA, López-González E, González-Cordero F, Rodríguez-Rodríguez EE. Ventajas de las plaquetas alogénicas conservadas en el tratamiento de las úlceras de miembros inferiores [Carta al director]. Rev Cubana Hematol Inmunol Hemoter. 2013 [citado 19 Jun 2014];29(1):104-7. Disponible en: http://scielo.sld.cu/pdf/hih/v29n1/hih12113.pdf

14. Hee CK, Dines JS, Solchaga LA, Shah VR, Hollinger JO. Regenerative tendon and ligament healing: Opportunities with recombinant human platelet-derived growth factor BB-homodimer. Tissue Engineering. Part B: Reviews. 2012;18(3):225-34. doi:10.1089/ten.teb.2011.0603.

15. Greppi N, Mazzucco L, Galetti G, Bona F, Petrillo E, Smacchia C, et al. Treatment of recalcitrant ulcers with allogenic platelet gel from pooled platelets in aged hypomobile patients. Biologicals. 2011;39:73-80.

16. Hernández-Ramírez P. Medicina regenerativa y células madre. Mecanismos de acción de las células madre. Rev Cubana Hematol Inmunol Hemoter. 2009 [citado 19 Jun 2014];25(1). Disponible en: http://scielo.sld.cu/pdf/hih/v25n1/hih02109.pdf

17. Geremicca W, Fonte C, Vecchio S. Blood componentes for topical use in tissue regeneration: evaluatoin of corneal lesions treated with platelet lysate and considerations on repair mechanisms. Blood Transfus. 2010;8:107-12.

18. Jiménez Barragán K, González Sánchez J. Uso de plasma rico en factores de crecimiento para disminuir la recurrencia de fístulas nasopalatinas en pacientes con antecedentes de paladar hendido. An ORL Mex. 2011;56(2):63-75.